Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)

China flag China · Delayed Price · Currency is CNY
36.04
+0.55 (1.55%)
At close: Apr 29, 2026
-27.91%
Market Cap 15.06B
Revenue (ttm) 3.77B
Net Income (ttm) 482.30M
Shares Out 417.75M
EPS (ttm) 1.22
PE Ratio 29.54
Forward PE 30.80
Dividend 0.52 (1.46%)
Ex-Dividend Date n/a
Volume 774,884
Average Volume 870,057
Open 35.43
Previous Close 35.49
Day's Range 35.40 - 36.13
52-Week Range 35.00 - 49.99
Beta n/a
RSI 36.87
Earnings Date Apr 30, 2026

About SHA:603014

Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers; dialysis machines; hemodialysis tubing, products, and machines; peritoneal dialysis products; dialysis supporting products, such as hemoperfusion devices, dialysis powder and liquid, puncture needles, and iodine caps for peritoneal dialysis. The company was founded in 2004 and is based in Weihai, China. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 3,734
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603014
Full Company Profile

Financial Performance

In 2025, SHA:603014's revenue was 3.77 billion, an increase of 4.57% compared to the previous year's 3.60 billion. Earnings were 482.30 million, an increase of 7.33%.

Financial Statements

News

There is no news available yet.